Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

The recent reduction of live attenuated influenza vaccine (LAIV) effectiveness in multivalent formulations was particularly associated with the A(H1N1)pdm09 component. In the 2017 the WHO vaccine composition committee changed its recommendations for the A(H1N1)pdm09 component to include an A/Michiga...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine X
Hauptverfasser: Shcherbik, Svetlana, Pearce, Nicholas, Carney, Paul, Bazhenova, Ekaterina, Larionova, Natalie, Kiseleva, Irina, Rudenko, Larisa, Kumar, Amrita, Goldsmith, Cynthia S., Dugan, Vivien, Stevens, James, Wentworth, David E., Bousse, Tatiana
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2019
Schlagworte:
Regular paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668239/
https://ncbi.nlm.nih.gov/pubmed/31384746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100031
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge